First, the user selects the institution or PHYSICIAN OFFICE and enters an estimated total monthly number of Product cell patients, which can be comprised of a mix of Product A and Product B by the user. The number of patients attributed to each Product cell therapy is determined by the user. Next, the user can distribute a proportion of patients to the Indication 1 setting or the Indication 2 setting for Product A and the Indication 1 setting or the Indication 2 setting for Product B, respectively. The population is then further allocated between Medicare (Fee-For-Service and Medicare Advantage) and Commercial payers as determined by the user. Product cell therapy acquisition cost, non-Product cell therapy costs, Product cell therapy safety profiles, reimbursement methods, and patient cost sharing are user-modifiable inputs. The results can be pivoted to show a portfolio view (reimbursements less costs for all three payer types and both Product cell therapies), or detailed reimbursements and costs by payer type and by Product cell therapy.
Click the arrow buttons to
navigate between pages
Click the button above to
reset the defaults in the tool
Click the button above for
additional information
Click the button above to
turn the setting on or off
Non-modifiable Inputs
Input cells that are fixed based on
calculations from other inputs
Modifiable Inputs
User can modify the values
in these cells
Click the button above to
share results document
Click the button above to
view update notifications